What is ORGO's gross margin?

Organogenesis (ORGO) has a gross margin of 46% and a net margin of -227%.

What is ORGO's P/E ratio?

Track Organogenesis (ORGO) P/E ratio, ROE, and valuation metrics over time.

Where can I see ORGO's full financials?

See Organogenesis (ORGO) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

Organogenesis (ORGO) Financials — Revenue, Earnings, Cash Flow

$1.33

-0.07 (-5.00%)

Weekly Expected Move ±7.1%

$1 $1 $1 $1 $2

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Sell · Power 31 · $171.1M mcap · 57M float · 1.38% daily turnover · Short 64% of daily vol

📊 Key Metrics

TTM

$457M

Revenue

+6.4% YoY

$-90M

Net Income

-996.2% YoY

$21M

Free Cash Flow

+144.9% YoY

45.9%

Gross Margin

-116.5%

Op. Margin

-227.0%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-27.8%

ROA-20.8%

ROIC-7.7%

Valuation

P/E-1.6

P/B0.6

EV/EBITDA-59.4

Leverage

Debt/Equity0.23

Current Ratio3.52

Interest Cov.-80.8x

Quality Scores

Piotroski F3/9

Altman Z2.34

Beneish M-3.51